Detalhe da pesquisa
1.
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials.
Blood
; 141(6): 579-591, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130300
2.
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.
MMWR Morb Mortal Wkly Rep
; 72(22): 601-605, 2023 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37262007
3.
Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
Clin Infect Dis
; 75(Suppl 2): S254-S263, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35684973
4.
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.
Blood
; 136(2): 199-209, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325491
5.
Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells.
Prostate
; 75(11): 1137-49, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25893276
6.
Co-migration of colon cancer cells and CAFs induced by TGFß1 enhances liver metastasis.
Cell Tissue Res
; 359(3): 829-39, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557989
7.
Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel.
Blood Cancer Discov
; 4(5): 365-373, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486974
8.
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology.
Blood Adv
; 6(2): 690-703, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587246
9.
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.
Cancers (Basel)
; 13(19)2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638406
10.
Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.
BMC Cancer
; 10: 188, 2010 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20459769
11.
The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.
Clin Cancer Res
; 25(10): 3176-3187, 2019 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30692097
12.
The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.
Cancer Lett
; 356(2 Pt B): 899-909, 2015 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25449776